Does NIH comply with 40 USC 559, and consult Department of Justice when issuing exclusive patent licenses? Apparently not.
Author: James Love
FDA asked to ban music in pharmaceutical ad discussions of side effects and risks
Knowledge Ecology International (KEI), the Center for Digital Democracy (CDD), and three individuals, Manon Ress, Professor Liza Vertinsky, from Emory Law School and Dr. Reshma Ramachandran, a fellow at Yale University School of Medicine, have filed a citizens petition with… Continue Reading
Joint letter to Dr. Fauci at NIAID, regarding the geographic scope of RNAceuticals HIV patent license, asks that exclusivity not extend to countries with low and moderate incomes
Below is a letter from several individuals and groups, asking that NIAID not grant exclusive rights in a HIV patent license for South Africa, India and other low income countries. (PDF version here) The license is to RNAceuticals, a firm… Continue Reading
What is a Global Public Good?
Below is a link to an essay on the use of the phrase “global public goods”. The essay focuses on the three papers Paul Samuelson wrote in the 1950s that are often used, and misused, to define public goods. Samuelson’s… Continue Reading
KEI at WIPO conversation on intellectual property (IP) and artificial intelligence (AI)
The second session of the WIPO Conversation on IP and AI is being held over three days from July 7 to 9, 2020. WIPO’s web page on the event is here. I had submitted comments earlier to both WIPO and… Continue Reading
KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards
KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading
KEI response to four GAO questions on transparency of ownership and management of intellectual property HHS funds
On June 3, 2020, the U.S. Government Accountability Office (GAO) sent KEI four questions about the transparency of the intellectual property HHS owns and how HHS manages those rights. On June 22, 2020, we sent this response. KEI response to… Continue Reading
Statement of Knowledge Ecology International (KEI) on WHO Launch of the COVID-19 Technology Pool
Statement of Knowledge Ecology International (KEI) on WHO Launch of the COVID-19 Technology Pool May 29, 2020. KEI supports the “WHO Solidarity Call to Action: To realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property… Continue Reading
AstraZeneca, Pfizer, IFPMA on the WHO COVID-19 Pool at May 28, 2020 IFPMA Press Briefing
At a May 28,2020 press briefing organized by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), pharma CEOs and the IFPMA DG commented on the WHO proposal for a global pool for rights in technologies for the diagnosis, prevention… Continue Reading
Moderna and US Government Funding of its COVID-19 Vaccine Candidate
(More on Moderna here: https://www.keionline.org/moderna) (Updated to include modernatx patents) The biotech company Moderna is in the news this week, after making an announcement of early clinical results for mRNA-1273, a vaccine candidate against novel coronavirus (SARS-CoV-2). The early and… Continue Reading